Swiss eyecare firm Alcon said on Monday it has agreed to a deal worth a potential $430 million with US counterpart Lensar, which offers advanced laser solutions for cataract treatments.
Swiss eyecare firm Alcon said on Monday it has agreed to a deal worth a potential $430 million with US counterpart Lensar, which offers advanced laser solutions for cataract treatments.
Leave A Comment